Localization of complement component 3 on Streptococcus pneumoniae: anti-capsular antibody causes complement deposition on the pneumococcal capsule
- 1 January 1983
- journal article
- research article
- Published by American Society for Microbiology in Infection and Immunity
- Vol. 39 (1) , 403-409
- https://doi.org/10.1128/iai.39.1.403-409.1983
Abstract
We have previously shown that complement component 3 (C3) deposited onto encapsulated Streptococcus pneumoniae by anti-capsular antibody (Ab) is a more efficient opsonin in vitro and in vivo than C3 deposited by anti-cell wall Ab (Brown et al., J. Clin. Invest. 69:85-98, 1982). In the present study, we explored the cellular location of C3b molecules that differ in opsonic efficiency by using avidin-ferritin to localize biotinylated Ab and C3 molecules on S. pneumoniae for electron microscopy. Anti-cell wall Ab and C3b molecules deposited by this Ab on unencapsulated S. pneumoniae were localized to S. pneumoniae cell walls. Anti-capsular Ab and C3b deposited by this Ab were seen in clusters on encapsulated S. pneumoniae at a distance from the cell wall. However, no avidin-ferritin staining of encapsulated S. pneumoniae was seen on incubation with biotinyl-anti-cell wall Ab, biotinylated C3 fixed by anti-cell wall Ab, or nonimmune serum containing biotinyl-C3. In each case, uptake of the biotinylated component was proven by radioactivity measurements, since biotinylated Ab and C3 were also radiolabeled with 125I. When avidin-ferritin did not bind to biotinylated components. Ouchterlony analysis indicated that C3 was bound to cell wall components on the encapsulated organisms. Thus, we conclude that, for encapsulated S. pneumoniae, opsonically efficient C3b molecules, deposited by anti-capsular Ab, are located on the S. pneumoniae capsule, whereas the opsonically inefficient C3b molecules deposited by anti-cell wall Ab or nonimmune serum are located on the cell wall. A major reason for the increased virulence of encapsulated compared to unencapsulated S. pneumoniae is that, in the absence of anti-capsular Ab, the S. pneumoniae capsule interferes with the recognition of cell wall-bound C3b molecules by phagocytic cell receptors.This publication has 14 references indexed in Scilit:
- Biotinylation of human C3Molecular Immunology, 1982
- A quantitative analysis of the interactions of antipneumococcal antibody and complement in experimental pneumococcal bacteremia.Journal of Clinical Investigation, 1982
- Large scale isolation of functionally active components of the human complement system.Journal of Biological Chemistry, 1981
- IMPAIRED IMMUNE RESPONSE OF SPLENECTOMISED PATIENTS TO POLYVALENT PNEUMOCOCCAL VACCINEThe Lancet, 1981
- Activation of C3 via the alternative complement pathway results in fixation of C3b to the pneumococcal cell wall.The Journal of Immunology, 1980
- [55] The avidin-biotin complex in affinity cytochemistryPublished by Elsevier ,1979
- Activation of the Alternative Complement Pathway by Pneumococcal Cell Wall Teichoic AcidThe Journal of Immunology, 1978
- Activation of the Alternative Pathway by Pneumococcal Cell WallsThe Journal of Immunology, 1977
- The Role of the Capsular Polysaccharide in the Activation of the Alternative Pathway by the PneumococcusThe Journal of Immunology, 1976
- The isolation of IgG from mammalian sera with the aid of caprylic acidArchives of Biochemistry and Biophysics, 1969